GreenHouse Holdings, Inc. (OTCQB :GRHU) ("GreenHouse") is a leading provider of energy efficiency solutions and sustainable infrastructure products. The company designs, engineers and installs disparate products and technologies with visible return on investment, enabling our clients to reduce their energy costs. Our target markets for our energy efficiency solutions include residential, commercial and industrial, as well as government and military markets. In addition, we develop, design and construct rapidly deployable, sustainable infrastructure primarily for use in disaster relief and security in austere regions.
With 2011 just days away, GRHU encourages and assists companies of all sizes with efforts to identify and adopt strategies that fully incorporate the various incentive programs offered through their local utilities. These programs provide significant monetary incentives for acting on projects that improve energy efficiency and pays consumers for participating in periodic consumption reductions (Demand Response or DR) -- increasing a business' bottom line for the coming year.
GRHU provides energy efficiency services for customers including General Dynamics, Gulfstream Aerospace, PepsiCo and its burgeoning relationship with the United States Army. The U.S. military continues to embrace and expand its use of green solutions on its bases throughout the world, enhancing the fast-tracked penetration of a domestic consumer market for sustainable products and services.
GreenHouse has also retained Rubenstein Public Relations to generate media exposure for the company's efficient and environmentally sustainable innovations.
GRHU has also announced the results of operations for the third quarter of Fiscal Year 2010 and is providing a shareholder update.
Recently, Emissary Capital Group LLC Reaffirmed $7 price objective on GRHU .
To read the complete report, click here: http://pennyomega.com/img/GRHU_update_101810%20%282%29.pdf
Emissary Capital Group, LLC. is a New York City-based company that provides strategic consulting and research services to public emerging growth companies. The firm also provides a diversified array of services to small and medium sized private companies, generally defined as those with annual revenues under $200 million, in order to assist them to become publicly traded companies in the U.S.!
More about GRHU at: www.greenhouseintl.com
PDF Solutions Inc. (Nasdaq:PDFS) announced that the world leader of automotive, industrial, consumer goods and building Technologies Robert Bosch GmbH has selected its maestria(R) Fault Detection and Classification (FDC) as FDC solution for its eight-inch new semiconductor facility in Reutlingen, Germany. PDF Solutions will bring to Bosch its worldwide experience and knowledge to deploy its maestria(R) FDC tool across the whole facility and enable Bosch to receive the full benefit of the implementation of this Advanced Process Control solution for each wafer process step.
PDF Solutions, Inc. provides infrastructure technologies and services for the design and manufacture of integrated circuits(IC) in Asia, the United States, and Europe. It offers manufacturing process solutions that include process research and development, and process integration and yield ramp; volume manufacturing solutions; and design-for-manufacturability (DFM) solutions, such as logic DFM, circuit level DFM, memory DFM, and pdBRIX Physical IP solutions. The company also offers characterization vehicle (CV) infrastructure, which includes CV test chips.
China Gerui Advanced Materials Group Ltd. (Nasdaq:CHOP) announced the results of the Company's Annual Meeting of Shareholders (the "Annual Meeting"), which was held on December 8, 2010, in Zhengzhou, PRC.At the Annual Meeting, the following proposals were approved:Elected Maotong Xu and J.P. Huang as Class I Directors to hold office for a term of three years and until their successors have been duly elected or until each such person shall resign, be removed or otherwise leave office, elected Mingwang Lu, Yi Lu and Yunlong Wang as Class II Directors to hold office for a term of two years and until their successors have been duly elected or until each such person shall resign, be removed or otherwise leave office, and elected Kwok Keung Wong and Harry Edelson as Class III Directors to hold office for a term of one year and until their successors have been duly elected or until each such person shall resign, be removed or otherwise leave office;Ratified the appointment of UHY Vocation HK CPA Limited ("UHY") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2010; and Approved the China Gerui Advanced Materials Group Limited 2010 Share Incentive Plan.
China Gerui Advanced Materials Group Limited engages in the manufacture and sale of cold-rolled narrow strip steel products in the People's Republic of China. The company converts steel manufactured by third parties into thin steel sheets and strips. It sells its products directly to its customers in a range of industries, including food packaging, telecommunication, electrical appliance, and construction materials industries.
Cardiome Pharma Corp. (Nasdaq:CRME) has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.
Cardiome Pharma Corp., a life sciences company, focuses on developing drugs to treat or prevent cardiovascular diseases. The company?s product pipeline primarily includes Vernakalant (iv), which is in Phase III (ACT 5) clinical trials for the treatment of atrial fibrillation; Vernakalant (oral) that completed Phase IIa clinical trials and Phase IIb clinical trials for the treatment of atrial fibrillation; and GED-aPC, which completed Phase I clinical trials for the treatment of multiple disease states.
Power3 Medical Products Inc (OTC.BB:PWRM) signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
PWRM has delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3's diagnostic test, and focused on PWRM 's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
Alzheimer's gets worse over time. Alzheimer's disease is a developing condition, at which symptoms slowly intensify over a period of time. Continuing, memory loss is mild, however with late-stage Alzheimer's disease, people lose the ability to hold on a dialogue as well as react to their surroundings. Alzheimer's is the 6th main source of death in the united states. People with Alzheimer's are living an average of eight years following an individual's symptoms developing into being recognizable to many others, but yet survival may range from three to 20 years, based upon years of age and various medical ailments.
PWRM strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.
More about PWRM at: www.Power3Medical.com
Sign Up For Free Stock Alerts At http://crwewallstreet.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer:Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEWallStreet publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEWallStreet.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(Read more at http://crwewallstreet.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB: GRHU). In addition to the cash, Crown Equity Holdings Inc. (CRWE.OB) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).